Measurement and treatment research to improve cognition in schizophrenia: neuropharmacological aspects

被引:41
作者
Geyer, MA
Tamminga, CA
机构
[1] Univ Calif San Diego, Dept Psychiat 0804, La Jolla, CA 92093 USA
[2] Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA
关键词
Schizophrenia; Cognitive Deficit; Fenton; Validate Assessment Tool; Clinical Trial Site;
D O I
10.1007/s00213-004-1846-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:1 / 2
页数:2
相关论文
共 2 条
[1]   Breaking the log-jam in treatment development for cognition in schizophrenia: NIMH perspective [J].
Fenton, WS ;
Stover, EL ;
Insel, TR .
PSYCHOPHARMACOLOGY, 2003, 169 (3-4) :365-366
[2]   Medicine: What are the right targets for psychopharmacology? [J].
Hyman, SE ;
Fenton, WS .
SCIENCE, 2003, 299 (5605) :350-351